LEBANON, Indiana — Eli Lilly and Company plans to invest $2.1 billion in two new manufacturing sites at the LEAP Lebanon Innovation and Research District in Boone County. The sites will bring up to ...

LEBANON, Ind. — Eli Lilly and Company announced it has more than doubled its investment in its Lebanon manufacturing site. The new $5.3 billion commitment increases the company's total ...

LEBANON, Ind. — Indianapolis-based pharmaceutical giant Lilly on Wednesday announced another billion-dollar project coming to Boone County. The project will be in the LEAP Research and Innovation ...

Eli Lilly and Company kicked off the second day of the Indiana Global Economic Summit by announcing a $5.3 billion investment slated for a major tech park.

May 24—Eli Lilly and Co. announced this week that it will boost its investment in Lebanon to $9 billion. The company initially announced a $2.1 billion investment in May of 2022 but boosted that ...

Eli Lilly and Company has announced it will be investing $2.1 billion in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Apr. 17—Eli Lilly and Co. officials announced Monday the company will invest another $1.6 billion in its Lebanon facility, bringing the pharmaceutical giant's total investment here to $3.7 ...

Faced with overwhelming demand for its diabetes treatment Mounjaro and weight-loss treatment Zepbound, Indianapolis-based drugmaker Eli Lilly and Co. said Friday morning it plans to invest another ...

The new facility builds on Lilly's ongoing expansion in Lebanon. In May 2022, Lilly announced a $2.1bn investment in two new sites for active ingredients and modalities.

Eli Lilly and Co. said Wednesday it will invest an additional $4.5 billion at its manufacturing site at the LEAP Lebanon Innovation District in Boone County to create a new center for advanced ...

Indianapolis-based pharmaceutical company Eli Lilly broke ground Tuesday on its $4.5 billion facility in Lebanon. The Lilly Medicine Foundry will be a research and development facility located at ...

Eli Lilly expects to begin making medicines in Lebanon toward the end of 2026 – with operations scaling up through 2028. Price Action: LLY shares are up 0.09% at $809.14 at the last check on Friday.